[21基因复发风险评分在乳腺癌患者中的应用]

Q Chen1, H X Shen2, Y L Wang1

  • 1Department of Pathology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.

概括

21基因复发风险评分 (21-基因RS) 有效预测早期HR阳性,HER2阴性乳腺癌患者的预后和临床病理特征. 这一分数有助于识别高风险个体,指导潜在的治疗决策.